PEXXF logo

PT Tempo Scan Pacific Tbk (PEXXF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

PEXXF, $ (piyasa değeri 0) fiyatla Healthcare işi olan PT Tempo Scan Pacific Tbk'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 47/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 18 Mar 2026
47/100 AI Puanı

PT Tempo Scan Pacific Tbk (PEXXF) Sağlık ve Boru Hattı Genel Bakışı

CEOI Made Dharma Wijaya
Çalışanlar4545
MerkezJakarta, ID
Halka Arz Yılı2011
SektörHealthcare

PT Tempo Scan Pacific Tbk, an Indonesian-based company, manufactures and distributes pharmaceuticals, consumer products, and cosmetics, leveraging a strong brand portfolio including Bodrex and Marina, and a wide distribution network to serve both domestic and international markets within the healthcare and personal care sectors.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 18 Mar 2026

Yatırım Tezi

PT Tempo Scan Pacific Tbk presents a compelling investment case based on its established market position, diverse product portfolio, and extensive distribution network. The company's attractive P/E ratio of 7.51 and a high dividend yield of 8.00% suggest potential value for investors. A profit margin of 11.0% and gross margin of 37.2% reflect solid profitability. Growth catalysts include expanding its product lines and penetrating new international markets. However, investors may want to evaluate the risks associated with operating in a competitive market and potential regulatory changes in the pharmaceutical and consumer goods industries. The company's beta of 0.60 indicates lower volatility compared to the overall market.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $0.46B indicates a mid-sized company with potential for growth.
  • P/E ratio of 7.51 suggests the company may be undervalued compared to its earnings.
  • Profit Margin of 11.0% demonstrates efficient operations and profitability.
  • Gross Margin of 37.2% reflects the company's ability to manage production costs effectively.
  • Dividend Yield of 8.00% provides a significant return for investors, indicating a commitment to shareholder value.

Rakipler & Benzerleri

Güçlü Yönler

  • Strong brand recognition in Indonesia.
  • Extensive distribution network.
  • Diverse product portfolio.
  • Established market position.

Zayıflıklar

  • Dependence on the Indonesian market.
  • Limited international presence compared to global competitors.
  • Potential vulnerability to regulatory changes.
  • Exposure to currency fluctuations.

Katalizörler

  • Upcoming: Potential new product launches in the pharmaceutical and consumer goods segments within the next 12-18 months.
  • Ongoing: Expansion of distribution network in Southeast Asia to increase market reach.
  • Ongoing: Investments in research and development to drive innovation and product differentiation.
  • Upcoming: Potential partnerships with e-commerce platforms to boost online sales.
  • Ongoing: Government initiatives to improve healthcare access in Indonesia.

Riskler

  • Potential: Increasing competition from local and international players in the pharmaceutical and consumer goods industries.
  • Potential: Regulatory changes in the pharmaceutical and consumer goods sectors that could impact profitability.
  • Potential: Economic downturns in Indonesia and other key markets that could reduce consumer spending.
  • Ongoing: Currency fluctuations that could affect the company's financial performance.
  • Ongoing: Risks associated with operating in the OTC market, including limited liquidity and disclosure.

Büyüme Fırsatları

  • Expanding Product Lines: PT Tempo Scan Pacific Tbk has the opportunity to expand its product lines within the pharmaceutical and consumer goods segments. By investing in research and development, the company can introduce new products that cater to evolving consumer needs and preferences. The market for innovative healthcare and personal care products is growing, presenting a significant opportunity for PT Tempo Scan Pacific Tbk to increase its market share. This expansion can be achieved within the next 2-3 years with sufficient investment in R&D.
  • Penetrating New International Markets: PT Tempo Scan Pacific Tbk can leverage its existing distribution network to penetrate new international markets. Southeast Asia, in particular, offers significant growth potential due to its large population and increasing demand for healthcare and consumer goods. By tailoring its products to local preferences and establishing strategic partnerships, the company can successfully expand its international presence. This expansion could begin within the next year, focusing initially on neighboring countries.
  • Leveraging E-commerce Platforms: The increasing adoption of e-commerce in Indonesia and other Southeast Asian countries presents a significant growth opportunity for PT Tempo Scan Pacific Tbk. By partnering with leading e-commerce platforms and developing its own online sales channels, the company can reach a wider customer base and increase its sales. The e-commerce market in Indonesia is projected to grow significantly in the coming years, making this a strategic area for investment. This initiative can be implemented within the next 6-12 months.
  • Focusing on Herbal and Natural Products: With growing consumer interest in natural and herbal products, PT Tempo Scan Pacific Tbk can capitalize on this trend by expanding its range of herbal and natural remedies. By leveraging its existing brands and distribution network, the company can effectively market these products to health-conscious consumers. The market for herbal and natural products is expanding rapidly, presenting a significant opportunity for PT Tempo Scan Pacific Tbk to increase its market share. This can be achieved through targeted marketing campaigns and product development over the next 1-2 years.
  • Strengthening Distribution Network: PT Tempo Scan Pacific Tbk can further strengthen its distribution network by investing in logistics and infrastructure. By improving its supply chain efficiency and expanding its distribution reach, the company can ensure that its products are readily available to customers across Indonesia and other markets. A robust distribution network is crucial for maintaining a competitive edge in the consumer goods and pharmaceutical industries. This ongoing effort will solidify the company's market position.

Fırsatlar

  • Expanding into new international markets.
  • Developing new products and formulations.
  • Leveraging e-commerce platforms.
  • Capitalizing on the growing demand for herbal and natural products.

Tehditler

  • Increasing competition from local and international players.
  • Changing consumer preferences.
  • Economic downturns in Indonesia and other markets.
  • Regulatory challenges and compliance costs.

Rekabet Avantajları

  • Strong brand recognition in Indonesia and other markets.
  • Extensive distribution network across Indonesia.
  • Diverse product portfolio spanning pharmaceuticals, personal care, and cosmetics.
  • Established relationships with retailers and distributors.

PEXXF Hakkında

PT Tempo Scan Pacific Tbk, founded in 1970 and headquartered in Jakarta, Indonesia, has evolved into a prominent player in the pharmaceuticals, personal care, and distribution services industries. Originally known as PT Scanchemie, the company has grown into a diverse conglomerate with a significant presence in Indonesia and internationally. Its operations are divided into three main segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment focuses on the manufacturing and trading of pharmaceutical products and medical devices. The Consumer Products and Cosmetics segment produces a wide range of personal care items, cosmetics, and household products. These products are sold under well-known brands such as Bodrex, Oskadon, Marina, and MY BABY. The Distribution Services segment supports the company's operations through warehousing, freight forwarding, and marketing activities. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi, which provides a stable ownership structure. The company's commitment to research and development, combined with its extensive distribution network, positions it as a key player in the Indonesian market.

Ne Yaparlar

  • Manufactures and trades pharmaceutical products and medical devices.
  • Produces and distributes personal care items, cosmetics, and household products.
  • Sells products under brands like Bodrex, Marina, and MY BABY.
  • Provides warehousing and freight forwarding services.
  • Engages in advertising and promotion activities.
  • Conducts research and development for new products and formulations.
  • Offers information technology and communication network systems services.
  • Procures, distributes, and markets products.

İş Modeli

  • Manufacturing and selling pharmaceutical products and medical devices.
  • Producing and distributing consumer products, cosmetics, and household items.
  • Providing distribution and logistics services to support its operations.
  • Generating revenue through a diverse portfolio of brands and products.

Sektör Bağlamı

PT Tempo Scan Pacific Tbk operates in the competitive pharmaceutical and consumer goods industries in Indonesia and internationally. The Indonesian pharmaceutical market is experiencing growth driven by increasing healthcare awareness and government initiatives to improve access to healthcare. The consumer goods sector is also expanding due to rising disposable incomes and changing consumer preferences. PT Tempo Scan Pacific Tbk competes with both local and international players, including AIHLF, CCHWF, CKDXF, DFHL, and ORRRY. The company's established brands and distribution network provide a competitive advantage in this dynamic market.

Kilit Müşteriler

  • Consumers in Indonesia and international markets.
  • Retailers and distributors who sell PT Tempo Scan Pacific Tbk's products.
  • Hospitals and clinics that use the company's pharmaceutical products.
  • E-commerce platforms and online retailers.
AI Güveni: 71% Güncellendi: 18 Mar 2026

Finansallar

Grafik & Bilgi

PT Tempo Scan Pacific Tbk (PEXXF) hisse senedi fiyatı: Price data unavailable

Son Haberler

PEXXF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

PEXXF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

PEXXF için Wall Street fiyat hedefi analizi.

MoonshotScore

47/100

Bu puan ne anlama geliyor?

MoonshotScore, PEXXF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: I Made Dharma Wijaya

CEO

I Made Dharma Wijaya serves as the CEO of PT Tempo Scan Pacific Tbk, leading a large workforce of 4545 employees. His background encompasses extensive experience in the consumer goods and pharmaceutical industries. He has held various leadership positions within PT Tempo Scan Pacific Tbk, contributing to the company's strategic planning and operational efficiency. His expertise includes market analysis, product development, and distribution management. He is committed to driving innovation and growth within the company.

Sicil: Under I Made Dharma Wijaya's leadership, PT Tempo Scan Pacific Tbk has maintained its strong market position and expanded its product portfolio. He has overseen the implementation of key strategic initiatives, including investments in research and development and the expansion of the company's distribution network. His focus on operational excellence has contributed to improved profitability and efficiency. He has also played a key role in fostering a culture of innovation and collaboration within the company.

PEXXF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that PT Tempo Scan Pacific Tbk may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for stocks on the OTC Other tier is typically very low, with wide bid-ask spreads and limited trading volume. This can make it difficult for investors to buy or sell shares without significantly impacting the price. The lack of liquidity increases the risk of price volatility and makes it challenging to execute large trades. Investors should be prepared for potential delays and price fluctuations when trading PEXXF on the OTC market.
OTC Risk Faktörleri:
  • Limited financial disclosure.
  • Low liquidity and high price volatility.
  • Potential for fraud or manipulation.
  • Lack of regulatory oversight.
  • Higher risk of delisting or going out of business.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's liquidity and trading volume.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Confirm the legitimacy of the company's operations and assets.
Meşruiyet Sinyalleri:
  • Established operating history since 1970.
  • Presence in the pharmaceutical and consumer goods industries.
  • Recognizable brands such as Bodrex and Marina.
  • Subsidiary of PT Bogamulia Nagadi.
  • Employs a large workforce of 4545 employees.

Yatırımcılar PT Tempo Scan Pacific Tbk (PEXXF) Hakkında Ne Soruyor

PEXXF için değerlendirilmesi gereken temel faktörler nelerdir?

PT Tempo Scan Pacific Tbk (PEXXF) şu anda yapay zeka skoru 47/100, düşük puanı gösteriyor. Temel güçlü yan: Strong brand recognition in Indonesia.. İzlenmesi gereken birincil risk: Potential: Increasing competition from local and international players in the pharmaceutical and consumer goods industries.. Bu bir finansal tavsiye değildir.

PEXXF MoonshotScore'u nedir?

PEXXF şu anda MoonshotScore'da 47/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

PEXXF verileri ne sıklıkla güncellenir?

PEXXF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler PEXXF hakkında ne diyor?

PEXXF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

PEXXF'a yatırım yapmanın riskleri nelerdir?

PEXXF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Increasing competition from local and international players in the pharmaceutical and consumer goods industries.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

PEXXF'ın P/E oranı nedir?

PEXXF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için PEXXF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

PEXXF aşırı değerli mi, yoksa düşük değerli mi?

PT Tempo Scan Pacific Tbk (PEXXF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

PEXXF'ın temettü verimi nedir?

PT Tempo Scan Pacific Tbk (PEXXF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited analyst coverage for PEXXF due to its OTC listing.
  • Financial data based on available information and may not be fully comprehensive.
Veri Kaynakları

Popüler Hisseler